BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30349238)

  • 1. Factors contributing to hospitalization costs for patients with COPD in China: a retrospective analysis of medical record data.
    Li M; Wang F; Chen R; Liang Z; Zhou Y; Yang Y; Chen S; Ung COL; Hu H
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3349-3357. PubMed ID: 30349238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical factors and comorbidities affecting the cost of hospital-treated COPD.
    Deniz S; Şengül A; Aydemir Y; Çeldir Emre J; Özhan MH
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3023-3030. PubMed ID: 27980399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors contributing to high-cost hospital care for patients with COPD.
    Mulpuru S; McKay J; Ronksley PE; Thavorn K; Kobewka DM; Forster AJ
    Int J Chron Obstruct Pulmon Dis; 2017; 12():989-995. PubMed ID: 28392683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of hospitalization for stroke from two urban health insurance claims data in Guangzhou City, southern China.
    Zhang H; Yin Y; Zhang C; Zhang D
    BMC Health Serv Res; 2019 Sep; 19(1):671. PubMed ID: 31533714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchiectasis in patients hospitalized with acute exacerbation of COPD in Spain: Influence on mortality, hospital stay, and hospital costs (2006-2014) according to gender.
    Sánchez-Muñoz G; Lopez-de-Andrés A; Hernández-Barrera V; Jiménez-García R; Pedraza-Serrano F; Puente-Maestu L; de Miguel-Díez J
    PLoS One; 2019; 14(1):e0211222. PubMed ID: 30682190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospitalization costs of COPD cases and its associated factors: an observational study at two large public tertiary hospitals in Henan Province, China.
    Yu C; Xia Q; Li Q; Wu J; Wang X; Wu J
    BMC Geriatr; 2023 Jul; 23(1):457. PubMed ID: 37491188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in Hospitalization Expenditures for Acute Exacerbations of COPD in Beijing from 2009 to 2017.
    Liang L; Shang Y; Xie W; Shi J; Tong Z; Jalali MS
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1165-1175. PubMed ID: 32547004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COPD: Does Inpatient Education Impact Hospital Costs and Length of Stay?
    Hosseini HM; Pai DR; Ofak DR
    Hosp Top; 2019; 97(4):165-175. PubMed ID: 31621519
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic obstructive pulmonary disease (COPD) exacerbation: impact of comorbidities on length and costs during hospitalization.
    Terzano C; Colamesta V; Unim B; Romani S; Meneghini A; Volpe G; La Torre G
    Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3680-3689. PubMed ID: 28925473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct Hospitalization Cost of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Vietnam.
    Ngo CQ; Thi Bui T; Vu GV; Chu HT; Phan PT; Ngoc Pham H; Vu GT; Nguyen LH; Ha GH; Tran BX; Latkin CA; Ho CSH; Ho RCM
    Int J Environ Res Public Health; 2018 Dec; 16(1):. PubMed ID: 30598020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with hospitalisation costs in patients with chronic obstructive pulmonary disease.
    Li F; Sun Z; Li H; Yang T; Shi Z
    Int J Tuberc Lung Dis; 2018 Apr; 22(4):458-463. PubMed ID: 29562996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population.
    Schwab P; Dhamane AD; Hopson SD; Moretz C; Annavarapu S; Burslem K; Renda A; Kaila S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():735-744. PubMed ID: 28260880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and economic burden of patients diagnosed with COPD with comorbid cardiovascular disease.
    Dalal AA; Shah M; Lunacsek O; Hanania NA
    Respir Med; 2011 Oct; 105(10):1516-22. PubMed ID: 21684731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between disease severity, smoking index age and direct costs of hospital treatment of COPD exacerbations].
    Targowski T; Jahnz-Rózyk K; From S; Płusa T
    Pneumonol Alergol Pol; 2005; 73(1):32-5. PubMed ID: 16539181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of hospitalization expenditures and influencing factors for inpatients with coronary heart disease in a tier-3 hospital in Xi'an, China: A retrospective study.
    Ding JM; Zhang XZ; Hu XJ; Chen HL; Yu M
    Medicine (Baltimore); 2017 Dec; 96(51):e9341. PubMed ID: 29390516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of medical expenditure with nebulized budesonide versus systemic corticosteroids in hospitalized patients with acute exacerbations of chronic obstructive pulmonary disease in China.
    Zhang J; Yao W; You X; Liu T; Liu Y
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1195-1207. PubMed ID: 31213797
    [No Abstract]   [Full Text] [Related]  

  • 19. Economic burden of comorbidities among COPD Patients hospitalized for acute exacerbations: an analysis of a commercially insured population.
    Shah CH; Onukwugha E; Zafari Z; Villalonga-Olives E; Park JE; Slejko JF
    Expert Rev Pharmacoecon Outcomes Res; 2022 Jun; 22(4):683-690. PubMed ID: 34530664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease.
    Dalal AA; Roberts MH; Petersen HV; Blanchette CM; Mapel DW
    Int J Chron Obstruct Pulmon Dis; 2010 Dec; 6():13-22. PubMed ID: 21311689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.